Hong Kong Stock Exchange

Fosun International Expects One-off Negative Impact to be Cleared and Businesses to Bound Back in 2023

Retrieved on: 
Saturday, January 21, 2023
Daiwa Securities Group, Weather, PE, Club Med, Mainland China, China International Capital Corporation, CICC, Face, COVID-19, The Conference Board, Statistics, HKEX, Morgan Stanley, S&P Global, Vaccination, Fruit, Pfizer–BioNTech COVID-19 vaccine, Security, Tourism, Commerce, Happiness, NAV, Central Economic Work Conference, Conference, S&P Global Ratings, Policy, Omicron, Spring Festival, New Year, Hong Kong Stock Exchange, The Spring Festival, Optimism, Nanjing Iron and Steel Group, Retail, Pharmaceutical industry, Security (finance), Fosun International, Health, Azvudine

The announcement also pointed out that with the gradual return to normalization of international trade and commerce in 2023, the Company's management expects to see recovery of its businesses.

Key Points: 
  • The announcement also pointed out that with the gradual return to normalization of international trade and commerce in 2023, the Company's management expects to see recovery of its businesses.
  • The two flagships of Fosun's Happiness segment, Fosun Tourism Group and Yuyuan, and other businesses have shown strong signs of recovery.
  • Based on Fosun's solid financial performance and strong potential for rebound, Morgan Stanley and Daiwa Capital Markets reiterated their "Overweight"/"Buy" rating on Fosun International.
  • Nomura Orient International Securities, China Industrial Securities, and CICC have assigned Fosun International an "Overweight"/"Outperform" rating.

BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share

Retrieved on: 
Friday, January 13, 2023
Trust, Language isolate, International, Motherboard, Marketing, History, Growth, Danna International (Offer Nissim Presents), Teleport Communications Group, Neology, Hong Kong Stock Exchange, Stock exchange, CCASS, Property management

The Offer Price is HK$19.32 per share.

Key Points: 
  • The Offer Price is HK$19.32 per share.
  • The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been very significantly oversubscribed.
  • The Offer Shares initially offered under the International Offering have been moderately oversubscribed, representing approximately 4.7 times of the total number of 36,482,500 International Offer Shares initially available for subscription under the International Offering.
  • The outstanding share oversubscription shows the trust and support of global investors for the Company's business development and lays a firm ground for the Company's long-term growth.

SinoHytec Successfully Listed on the Main Board of HKEX

Retrieved on: 
Thursday, January 12, 2023
R, Trust, HKEX, International, Motherboard, Today, S. D. Warren Co. v. Maine Board of Environmental Protection, Danna International (Offer Nissim Presents), Research, Hong Kong Stock Exchange, Stock exchange, Renewable energy

SinoHytec adheres to the R&D principles of "Advance Research", "Continuous Development" and "In-depth Promotion".

Key Points: 
  • SinoHytec adheres to the R&D principles of "Advance Research", "Continuous Development" and "In-depth Promotion".
  • In addition, the Company plans to develop and manufacture membrane electrodes, another major fuel cell stack component, through its main associate company, Shanghai Maximfuelcell Technology Co., Ltd.
  • Mr. Zhang Guoqiang, Chairman, Executive Director and General Manager of SinoHytec said: "Today, SinoHytec is officially listed on the Main Board of the Hong Kong Stock Exchange, which is an important milestone in the Company's development and marks the entry of SinoHytec into the international capital market.
  • We would like to express our gratitude to our investors for their trust and support of SinoHytec.

Semiconductor Manufacturing International Corporation Fourth Quarter 2022 Webcast Conference Call

Retrieved on: 
Tuesday, January 10, 2023
Hong Kong Stock Exchange, Shanghai Stock Exchange, SMIC, Clothing

SHANGHAI, Jan. 10, 2023 /PRNewswire/ -- SMIC's fourth quarter 2022 results will be released on the Hong Kong Stock Exchange website (https://www.hkex.com.hk) and Shanghai Stock Exchange website (http://www.sse.com.cn) after the close of trading on Thursday, February 09, 2023.

Key Points: 

SHANGHAI, Jan. 10, 2023 /PRNewswire/ -- SMIC's fourth quarter 2022 results will be released on the Hong Kong Stock Exchange website ( https://www.hkex.com.hk ) and Shanghai Stock Exchange website ( http://www.sse.com.cn ) after the close of trading on Thursday, February 09, 2023.

Kingsoft Cloud's Dual Primary Hong Kong Listing: Resilience Rooted in Technology-based Business, High-quality Development Expected from Improving Profitability

Retrieved on: 
Friday, December 30, 2022
Cloud, Tao, Ecosystem, ESG, Smartphone, COVID-19, CFO, S. D. Warren Co. v. Maine Board of Environmental Protection, Big data, Turnaround ADR, Motherboard, Hong Kong Stock Exchange, Cloud computing, Pressure, IOT, Video game console

In combination with in-depth understanding of strategically selected verticals, Kingsoft Cloud accomplished fast growth in both business scale and financials.

Key Points: 
  • In combination with in-depth understanding of strategically selected verticals, Kingsoft Cloud accomplished fast growth in both business scale and financials.
  • Kingsoft Cloud made proactive adjustments, allocated resources in favor of more profitable products and projects to achieve improved sustainability, profitability and operating cash flow.
  • Kingsoft Cloud has always been strongly supported by the strategic shareholders Xiaomi and Kingsoft Group.
  • He Haijian, CFO of Kingsoft Cloud, also said, "Primary listing in Hong Kong will broaden our investor base, facilitate our participation in Hong Kong Stock Connect, and open up investment cooperation channels to more Chinese mainland investors.

SinoHytec Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange, Offer Price Between HK$60 and HK$76 per H Share, Raise up to HK$1,540.7 million

Retrieved on: 
Thursday, December 29, 2022
Government, Lithium, MEA, Research, Tsinghua University, State Intellectual Property Office (Croatia), Toyota, S. D. Warren Co. v. Maine Board of Environmental Protection, Hong Kong Stock Exchange, Motherboard, R, City, 3rd millennium, Yutong, Safety, Stock exchange, CIC, Danna International (Offer Nissim Presents), Foton Motor, Houston Advanced Research Center, Patent, Carbon, United Nations, United Nations Development Programme, International, Property management, Renewable energy, PRC

The Hong Kong Public Offering will commence at 9 a.m., December 29, 2022 (Thursday), and close at 12:00 noon on January 5, 2023 (Thursday).

Key Points: 
  • The Hong Kong Public Offering will commence at 9 a.m., December 29, 2022 (Thursday), and close at 12:00 noon on January 5, 2023 (Thursday).
  • Dealings in the shares of SinoHytec on the Main Board of the Hong Kong Stock Exchange is expected to commence on January 12, 2023 (Thursday), with the stock code 2402 and in board lots of 50 Offer Shares each.
  • Established in 2012, the company is a pioneer in the R&D and commercialization of fuel cell systems in China and started batch production in 2016.
  • As of December 20, 2022, the company's fuel cell systems have powered over 2,800 fuel cell vehicles on the road in China.

Austasia Group in The Progress of IPO: One of The Top Five Dairy Farm Operators in China with Bright Future

Retrieved on: 
Tuesday, December 20, 2022
IPO, The Company, China International Capital Corporation, Hong Kong Exchanges and Clearing, Dairy, Prospectus, Growth, Hong Kong Stock Exchange, Health, Coffee, Bloomberg Terminal, Milk

On 16 December, AustAsia Group Ltd. ("AUSTASIA GROUP" or the "Company"; stock code: 2425.HK), a dairy farm operator, officially launched its IPO, which has now entered the third day.

Key Points: 
  • On 16 December, AustAsia Group Ltd. ("AUSTASIA GROUP" or the "Company"; stock code: 2425.HK), a dairy farm operator, officially launched its IPO, which has now entered the third day.
  • According to the prospectus, AUSTASIA GROUP is one of the top five dairy farm operators in China, ranking third, fourth and fifth among all dairy farm operators in China in terms of sales volume, sales value and production volume of raw milk in 2021.
  • As an essential people's livelihood industry, the dairy industry in China has been developing rapidly since the reform and opening up.
  • AUSTASIA GROUP currently owns and operates ten large-scale dairy farms in China, with an aggregate gross land area of approximately 14,657 mu.

Faraday Future Appoints Mr. Xuefeng Chen and Ms. Ke Sun to Board of Directors

Retrieved on: 
Thursday, December 29, 2022
Vehicle Technology, Luxury, Automotive, Technology, Automotive Manufacturing, Manufacturing, Mobile, Wireless, General Automotive, Retail, Environment, Transportation, Travel, Finance, Alternative Energy, Energy, Professional Services, Software, EV, Electric Vehicles, Internet, Hardware, Alternative Vehicles, Fuels, PEMAC Asset Management Association of Canada, Software, BAIC Motor, Fortune Global 500, Asian Institute of International Financial Law, Original equipment manufacturer, Faraday Future, Shanghai Stock Exchange, SOP, Shareholder, Multimedia, BAIC, Asset Management Association of China, FF, Dalian Maritime University, Shanghai Stock Exchange STAR Market, PT, Shareholders' agreement, Astana International Financial Centre, OEM, Hong Kong Stock Exchange

Faraday Future (NASDAQ: FFIE) ("FF" or “the Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that FF Global CEO Xuefeng (“XF”) Chen and Ms. Ke Sun have been appointed to FF’s Board of Directors, effective December 27, 2022.

Key Points: 
  • Faraday Future (NASDAQ: FFIE) ("FF" or “the Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that FF Global CEO Xuefeng (“XF”) Chen and Ms. Ke Sun have been appointed to FF’s Board of Directors, effective December 27, 2022.
  • Mr. XF Chen and Ms. Ke Sun fill the vacancies on the Board due to the resignations of Dr. Carsten Breitfeld and Mr. Edwin Goh, who both stepped down from the Board effective as of December 26, 2022.
  • View the full release here: https://www.businesswire.com/news/home/20221229005298/en/
    Ms. Ke Sun appointed to Faraday Future's Board of Directors.
  • Ms. Sun also served as the Secretary of the board of directors of BAIC Motor from September 2016 to September 2017.

IMAX Crowns "Avatar: The Way of Water" as its Highest Grossing Film of 2022, With $160 Million and Counting

Retrieved on: 
Tuesday, January 3, 2023
Avatar, NYSE, IMAX, Architecture, IMAX 3D, IMAX Corporation, Water, Hong Kong Stock Exchange, Film, Dome, 3D, Avatar 2, Twitter

NEW YORK, Jan. 3, 2023 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX) today announced that Disney/Lightstorm's "Avatar: The Way of Water" ended 2022 as the highest grossing release of the year in IMAX®, and that its total IMAX global box office is $160 million and counting through Monday. James Cameron's sci-fi sequel now stands as the fourth highest grossing IMAX release of all time. The film is already the highest grossing IMAX release of all time in eighteen markets worldwide, and IMAX has delivered 11% of the film's global gross to date on just a fraction of total screens.

Key Points: 
  • James Cameron's sci-fi sequel now stands as the fourth highest grossing IMAX release of all time.
  • Through Monday, "Avatar: The Way of Water" had grossed $58 million in IMAX domestically, with IMAX claiming 13.1% of North American grosses.
  • Internationally, IMAX has grossed $102 million with "Avatar: The Way of Water" — only the third IMAX release ever to cross $100 million in international box office.
  • IMAX®, IMAX® Dome, IMAX® 3D, IMAX® 3D Dome, Experience It In IMAX®, The IMAX Experience®, An IMAX Experience®, An IMAX 3D Experience®, IMAX DMR®, DMR®, Filmed For IMAX™, IMAX LIVE™, IMAX Enhanced™, IMAX nXos®, SSIMWAVE® and Films to the Fullest®, are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions.

Antengene to Present at the 41st Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 3, 2023
Annual report, Compugen (Israeli company), Patient, NDAS, Hematology, Greater, Selinexor, Conference, SEHK, Hong Kong Stock Exchange, PST, IND, Therapy, NDA, Risk, Pharmaceutical industry

SHANGHAI and HONG KONG, Jan. 3, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that Antengene will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th, 2023 at 9:30 a.m. PST in San Francisco, California.

Key Points: 
  • SHANGHAI and HONG KONG, Jan. 3, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that Antengene will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th, 2023 at 9:30 a.m. PST in San Francisco, California.
  • The presentation will be made by Dr. Jay Mei, Antengene's Founder, Chairman and CEO.
  • Details of the event are as follow:
    An archived version of the presentation also will be available on the Company website following the live presentation.
  • You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect.